. . . . . . . "[In this randomized double-blind exploratory study, 60 naive patients of HCV infection were assigned to receive either interferon?2a (IFN?2a) (3 mIU, subcutaneous, thrice weekly), ribavirin (RBV) (1000 mg, orally, twice daily in divided doses) and placebo (n = 30) or IFN?2a, RBV and Q-e-I (5 g, orally, thrice daily in divided doses) (n = 30).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:13:36+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .